This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Women's Health, Other  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Mike Mitka

JAMA. 2006;295:20-21.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Dallas—Scientists continue to discover benefits of aspirin use for women in preventing or reducing risk of cardiovascular disease and stroke. But are clinicians and patients getting the news?

Findings presented at the American Heart Association's Scientific Sessions held here in November highlighted contradictions that continue to surround aspirin use by women.

New research findings suggest that a daily regimen of low-dose aspirin may be associated with reduced risk of all-cause and cardiovascular mortality in older women. (Photo credit: Sheila Terry/www.sciencesource.com)

Current research holds that aspirin works for risk reduction in women with established cardiovascular disease but may not reduce risk for women without established disease. Much of this knowledge has emerged from subset analysis of major trials primarily involving men, or from more recently published trials focusing specifically on women. Indeed, the most definitive findings on primary prevention came just earlier this year with publication . . . [Full Text of this Article]

ASPIRIN UNDERUSED